A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute biphenotypic leukemia, acute myeloid leukemia, bone marrow disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, mixed phenotype acute leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm	Recruiting	Phase 1	2026-09-29		NCT03802695

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Orca Biosystems, Inc.	8

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
City of Hope	Duarte	United States	238
Emory University	Atlanta	United States	262
Fred Hutchinson Cancer Center	Seattle	United States	250
Froedtert Memorial Lutheran Hospital	Milwaukee	United States	6
John Theurer Cancer Center at Hackensack University Medical Center	Hackensack	United States	37
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Moffitt Cancer Center	Tampa	United States	523
Ohio State University	Columbus	United States	169
Stanford Health Care	Stanford	United States	20
The University of Kansas Hospital	Kansas City	United States	11
UC Davis	Sacramento	United States	25
University of Texas MD Anderson Cancer Center	Houston	United States	2